20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T8579 | Nav1.8-IN-1 | 5-(4-Chlorophenyl)-N-[[2-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl]pyridine-3-carboxamide,CHEMBL1270208 | Sodium Channel |
Nav1.8-IN-1 (CHEMBL1270208) is an inhibitor of human NaV1.8 | |||
T77693 | Nav1.8-IN-4 | Sodium Channel | |
Nav1.8-IN-4 is a potent Nav1.8 channel inhibitor with potential analgesic activity.Nav1.8-IN-4 can be used for pain and neurological related disorders. | |||
T62422 | Nav1.8-IN-2 | ||
Nav1.8-IN-2 (compound 35A) is a potent inhibitor of Nav1.8 (IC50: 0.4 nM). Nav1.8-IN-2 can be used in studies of pain disorders, cough, acute and chronic pruritus. | |||
T2024 | A-803467 | A 803467,A803467 | Sodium Channel |
A-803467 is a selective NaV1.8 channel blocker. | |||
T4490 | PF-01247324 | Sodium Channel | |
PF-01247324 is a selective and orally bioavailable Nav1.8 channel blocker (IC50: 196 nM). | |||
T12424 | PF-06305591 | PF-6305591 | Others |
PF-06305591 is an effective and selective blocker of voltage-gated sodium channel NaV1.8 (IC50 = 15 nM). | |||
T62000 | ABBV-318 | ||
ABBV-318 can be used as small molecule Nav1.7/Nav1.8 blockers for the treatment of pain, with IC50 values of 2.8 μM for hNav1.7 and 3.8 μM for hNav1.8. ABBV-318 can be used to study pain-related disorders. | |||
T12421 | PF-04885614 | Sodium Channel | |
PF-04885614 is a potent inhibitor of NaV1.8, has potential for neurological and neurodevelopmental diseases treatment. | |||
T15174 | DSP-2230 | Sodium Channel | |
DSP-2230 is a selective blocker of Nav1.7/Nav1.8. | |||
TN1254 | 3'-Methoxydaidzein | Sodium Channel | |
3'-Methoxydaidzein is a dual isoflavone and Sodium Channel inhibitor. 3'-Methoxydaidzein inhibited NaV1.7, NaV1.8 and NaV1.3 with IC50 of 181 nM, 397 nM and 505 nM, respectively. 3'-Methoxydaidzein was specific for colla... | |||
T9683 | VX-150 | Sodium Channel | |
VX-150 is a highly selective NaV1.8 inhibitor relative to the other sodium channel subtypes (>400-fold). | |||
T16514 | PF 04531083 | Others , Sodium Channel | |
PF 04531083 is a selective blocker of the NaV1.8 channel. PF 04531083 can be used for neuropathic and inflammatory pain studies. | |||
T69552 | Suzetrigine | VX-548 | Sodium Channel |
Suzetrigine(VX-548) is an orally active and specific NaV1.8 inhibitor. Suzetrigine has analgesic activity and can be used to study acute pain and neurotransmission. | |||
T37688 | Cyfluthrin | Reactive Oxygen Species , Sodium Channel | |
Cyfluthrin binds to voltage-sensitive sodium channel such as Nav 1.8 sodium channel and modify their gating kinetics, thereby disrupting nerve function of pests. | |||
T7336 | ICA-121431 | 2,2-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl | Sodium Channel |
ICA-121431 (2,2-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl) is a nanomolar potent small molecule Nav1.7 channel inhibitor with IC50 of 19 nM for rat Nav1.7, with little or no activity against human Nav1.5 or Nav1.7 channels. | |||
T23136 | PF 04885614 | Others | |
NaV1.8 inhibitor | |||
T78955 | Analgesic agent-2 | Sodium Channel | |
Analgesic Agent-2, a selective orally active inhibitor of the NaV1.8 channel, demonstrates an IC50 of 50.18 nM in HEK293 cells that stably express the human NaV1.8 channel, indicating its potential for analgesic activity... | |||
T80435 | Heteropodatoxin-1 | Potassium Channel | |
Heteropodatoxin-1 (HpTx1), a spider peptide toxin, acts as an inhibitor of the Kv4.2 current, while concurrently inhibiting Nav1.7 and activating Nav1.9 channels. However, it has no effect on Nav1.8 channels [1]. | |||
T60761 | PF-06305591 dihydrate | ||
PF-06305591 dihydrate is a potent and highly selective voltage gated sodium channel NaV1.8 blocker (IC 50 = 15 nM) with an excellent preclinical in vitro ADME and safety profile [1]. | |||
TP1968 | ProTx-I | ProTx I | |
Selective CaV3.1 channel blocker (IC50 values are 0.2 and 31.8 μM for hCaV3.1 and hCaV3.2 respectively). Also reversibly inhibits NaV1.8 and blocks KV2.1 channels. |